Recombinant Human Thrombopoietin Increases Platelet Number and Reduces the Risk of Bleeding Events in Thrombocytopenic Patients with Chronic Hepatitis B Virus Infection: A Multicenter Observational Study
第一作者机构:[1]Peking Univ, Peoples Hosp, Inst Hematol,Collaborat Innovat Ctr Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Zhai Wan-Yi,Feng Ru,Zhu Xiao-Lu,et al.Recombinant Human Thrombopoietin Increases Platelet Number and Reduces the Risk of Bleeding Events in Thrombocytopenic Patients with Chronic Hepatitis B Virus Infection: A Multicenter Observational Study[J].BLOOD.2018,132:doi:10.1182/blood-2018-99-116000.
APA:
Zhai, Wan-Yi,Feng, Ru,Zhu, Xiao-Lu,He, Yun,Fu, Hai-Xia...&Zhang, Xiaohui.(2018).Recombinant Human Thrombopoietin Increases Platelet Number and Reduces the Risk of Bleeding Events in Thrombocytopenic Patients with Chronic Hepatitis B Virus Infection: A Multicenter Observational Study.BLOOD,132,
MLA:
Zhai, Wan-Yi,et al."Recombinant Human Thrombopoietin Increases Platelet Number and Reduces the Risk of Bleeding Events in Thrombocytopenic Patients with Chronic Hepatitis B Virus Infection: A Multicenter Observational Study".BLOOD 132.(2018)